-
4201por Avila, Mirla, Tan, Yuanyuan, Hernandez, Roberto, Zuberi, Hafsa, Rivera, Victor M.“…The two vaccinated patients had received two doses of the monovalent COVID-19 messenger ribonucleic acid (mRNA) (Pfizer Biotech) vaccine and no booster, a year prior to contracting COVID-19. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4202por Cerbino-Neto, José, Peres, Igor Tona, Varela, Margareth Catoia, Brandão, Luciana Gomes Pedro, de Matos, Juliana Arruda, Pinto, Luiz Felipe, da Costa, Marcellus Dias, Garcia, Márcio Henrique de Oliveira, Soranz, Daniel, Maia, Maria de Lourdes de Sousa, Krieger, Marco Aurélio, da Cunha, Rivaldo Venâncio, Camacho, Luiz Antonio Bastos, Ranzani, Otavio, Hamacher, Silvio, Bozza, Fernando Augusto, Penna, Gerson Oliveira“…Being vaccinated with Pfizer or AstraZeneca (Beta = 2.2; 95% CI = 1.8, 2.6) determined higher antibody titers than those observed with CoronaVac (Beta = 1.2; 95% CI = 0.9, 1.5). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4203por Vollbach, Kristina, Tenbrock, Klaus, Wagner, Nobert, Horneff, Gerd, Klein, Ariane, Foeldvari, Ivan, Haas, Johannes-Peter, Aries, Peer, Gauler, Georg, Striesow, Frank, Hoff, Paula, Scholz, Christine, Tatsis, Stefanie, Seipelt, Eva, Klotsche, Jens, Minden, Kirsten“…Of these, 74% had switched from Enbrel(®) (Pfizer Inc., NYC, USA) the originator of etanercept to Benepali(®) for cost reasons. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4204por Schechner, Vered, Wullfhart, Liat, Temkin, Elizabeth, Feldman, Sarah F, Nutman, Amir, Shitrit, Pnina, Schwaber, Mitchell J, Carmeli, Yehuda“…DISCLOSURES: Yehuda Carmeli, MD, Allecra Therapeutics: Advisor/Consultant|MSD: Advisor/Consultant|Nabriva: Advisor/Consultant|Pfizer: Advisor/Consultant|Qpex Pharmaceuticals: Advisor/Consultant|Roche: Advisor/Consultant|Shinogi: Advisor/Consultant|Spero Therapeutics: Advisor/Consultant.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4205por Guh, Alice, Winston, Lisa Gail, Johnston, Helen, Basiliere, Elizabeth, Olson, Danyel M, Fridkin, Scott, Goodenough, Dana, Wilson, Christopher, Watkins, Jasmine, Korhonen, Lauren C, Gerding, Dale N“…DISCLOSURES: Scott Fridkin, MD, Pfizer: Grant/Research Support Dale N. Gerding, MD, Destiny Pharma plc.: Advisor/Consultant.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4206por Quilter, Laura A, Tang, Eric C, Johnson, Kelly A, Jacobson, Kathleen, Ridpath, Alison, Cohen, Stephanie, Rajagopalan, Shobita, Munoz, Monica D, Holderman, Justin L, Kent, James B, Bachmann, Laura H, Bernstein, Kyle“….: Stocks/Bonds|Allogene Theraputics: Stocks/Bonds|Amarin Corperation PLC: Stocks/Bonds|infinity Pharmaceutical Companies: Stocks/Bonds|IQVIA Holdings Inc: Stocks/Bonds|Johnson and Johnson: Stocks/Bonds|Medtronic: Stocks/Bonds|pfizer: Stocks/Bonds|Thermo Fisher Scientific: Stocks/Bonds.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4207por Thompson, George R, King, Thomas, Azie, Nkechi, Angulo, David A, Prattes, Juergen“…Thompson, III, MD, Amplyx: Advisor/Consultant|Amplyx: Grant/Research Support|Astellas: Advisor/Consultant|Astellas: Grant/Research Support|Cidara: Advisor/Consultant|Cidara: Grant/Research Support|F2G: Advisor/Consultant|F2G: Grant/Research Support|Merck: Grant/Research Support|Pfizer: DSMB|Scynexis: Advisor/Consultant|Scynexis: Grant/Research Support Thomas King, MS MPH, SCYNEXIS, Inc.: employee|SCYNEXIS, Inc.: Stocks/Bonds Nkechi Azie, MD MBA FIDSA, SCYNEXIS, Inc.: employee|SCYNEXIS, Inc.: Stocks/Bonds David A. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4208por Patel, Twisha S, McGovern, Olivia L, Mahon, Garrett W, Boszczowski, Icaro, Munita, Jose M, Garzon, Maria I, Lipari, Flavio, Salomao, Matias, Marssola, Giovanna, Tavares, Bruno, Francisco, Debora, Gurgel, Alessandra P A, Arantes, Tiago, Bori, Andrea, Nogueira, Cassimiro, Peters, Anne, Spencer, Maria, Orellana, Cristian, Barbe, Mario, Roldán, Analía, Lopez, Constanza, Bortoletto, Josefina, Stender, Stacie C, Lessa, Fernanda C“…Munita, MD, BioMerieux: Grant/Research Support|MSD: Grant/Research Support|Pfizer: Grant/Research Support Matias Salomao, MD, Cepheid: Lecture.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4209“…DISCLOSURES: Scott Fridkin, MD, Pfizer: Grant/Research Support Colleen Kraft, MD MS, Rebiotix Inc: Advisor/Consultant|SERES: Advisor/Consultant.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4210por Dionne, Jodie, Pol, Barbara Van Der, Long, Dustin, Tih, Pius, Mbah, Rahel, Ngah, Edward, Pekwarake, Seraphine, Kifem, Mirabelle, Fondzeyuf, Anthony, Bruxvoort, Katia J, Tita, Alan, Marrazzo, Jeanne“…Bruxvoort, PhD, MPH, Dynavax: Grant/Research Support|Gilead: Grant/Research Support|Glaxosmithkline: Grant/Research Support|Moderna: Grant/Research Support|Pfizer: Grant/Research Support|Seqirus: Grant/Research Support.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4211“…BACKGROUND: Five SARS-CoV-2 vaccines are approved in North America and/or Europe: Pfizer/BioNTech, Moderna, Janssen, Oxford-AstraZeneca and Novavax. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4212por Altarawneh, Heba N, Chemaitelly, Hiam, Ayoub, Houssein H, Tang, Patrick, Hasan, Mohammad R, Yassine, Hadi M, Al-Khatib, Hebah A, Smatti, Maria K, Coyle, Peter, Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul-Rahim, Hanan F, Nasrallah, Gheyath K, Al-Kuwari, Mohamed Ghaith, Butt, Adeel A, Al-Romaihi, Hamad Eid, Al-Thani, Mohamed H, Al Khal, Abdul Latif, Bertollini, Roberto, Abu-Raddad, Laith J“…METHODS: Six national, matched, test-negative case-control studies were conducted on a sample of 272,861 PCR-positive tests and 669,628 PCR-negative tests to estimate effectiveness of BNT162b2 (Pfizer-BioNTech) vaccine, mRNA-1273 (Moderna) vaccine, natural immunity due to prior infection with pre-Omicron variants, and hybrid immunity from prior infection and vaccination. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4213por Keintz, Mackenzie R, Torres, Cristina J, Miller, Molly M, Alexander, Bryan T, Lyden, Elizabeth, Lyden, Elizabeth, Lyden, Elizabeth, Ma, Jihyun, Van Schooneveld, Trevor C, Marcelin, Jasmine R“…Van Schooneveld, MD, bioMerieux: Advisor/Consultant|bioMerieux: Grant/Research Support|Insmed: Grant/Research Support|Merck: Grant/Research Support|Thermo-Fischer: Advisor/Consultant Jasmine R. Marcelin, MD, Pfizer (Grant reviewer): Honoraria.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4214por Farland, Leslie V., Khan, Sana M., Shilen, Alexandra, Heslin, Kelly M., Ishimwe, Providence, Allen, Alicia M., Herbst-Kralovetz, Melissa M., Mahnert, Nichole D., Pogreba-Brown, Kristen, Ernst, Kacey C., Jacobs, Elizabeth T.“…RESULT(S): The majority of our vaccinated sample received the Pfizer-BioNTech vaccine (58%), and were 26-35 years old (51%), non-Hispanic (84%), and White (88%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4215por Monte, Gabriele, Papetti, Laura, Ferilli, Michela Ada Noris, Ursitti, Fabiana, Moavero, Romina, Sforza, Giorgia, Panella, Elena, Tarantino, Samuela, Checchi, Martina Proietti, Vigevano, Federico, Palma, Paolo, Valeriani, Massimiliano“…All patients received SARS-CoV2 vaccination (BNT162b2-Pfizer-BioNTech). The median follow-up was 20 weeks (range 14-24) and only two patients complained pain at injection site, fever and fatigue. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4216por Langer, Jakob, Welch, Verna L., Moran, Mary M., Cane, Alejandro, Lopez, Santiago M. C., Srivastava, Amit, Enstone, Ashley L., Sears, Amy, Markus, Kristen J., Heuser, Maria, Kewley, Rachel M., Whittle, Isabelle J.Enlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4217por Simão, André Lopes, Palma, Carolina Santos, Izquierdo-Sanchez, Laura, Putignano, Antonella, Carvalho-Gomes, Angela, Posch, Andreas, Zanaga, Paola, Girleanu, Irina, Henrique, Mariana Moura, Araújo, Carlos, Degre, Delphine, Gustot, Thierry, Sahuco, Iván, Spagnolo, Elia, Carvalhana, Sofia, Moura, Miguel, Fernandes, Diogo AE., Banales, Jesus M., Romero-Gomez, Manuel, Trifan, Anca, Russo, Francesco Paolo, Stauber, Rudolf, Berenguer, Marina, Moreno, Christophe, Gonçalves, João, Cortez-Pinto, Helena, Castro, Rui E.“…IMPACT AND IMPLICATIONS: In patients with CLD vaccinated with two-dose vaccines, age, cirrhosis, and type of vaccine (Vaxzevria > Pfizer BioNTech > Moderna) predict a ‘lower’ humoral response, whereas viral hepatitis aetiology and prior antiviral therapy predict a ‘higher’ humoral response. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4218por Buchan, Sarah A., Alley, Sarah, Seo, Chi Yon, Johnson, Caitlin, Kwong, Jeffrey C., Nasreen, Sharifa, Thampi, Nisha, Lu, Diane, Harris, Tara M., Calzavara, Andrew, Wilson, Sarah E.“…EXPOSURE: Receipt of BNT162b2 (Comirnaty [Pfizer-BioNTech]) vaccine. MAIN OUTCOMES AND MEASURE: Reported incidence of myocarditis or pericarditis meeting level 1 to 3 of the Brighton Collaboration case definition per 100 000 doses of BNT162b2 administered by age group (12-15 years vs 16-17 years), sex, dose number, and interdose interval. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4219por Ludwikowska, Kamila M., Popiel, Aneta, Matkowska-Kocjan, Agnieszka, Olbromski, Mateusz J., Biela, Mateusz, Wójcik, Marta, Szenborn, Filip, Wielgos, Katarzyna, Pielka-Markiewicz, Ewa, Zaryczański, Janusz, Kursa, Miron B., Szenborn, Leszek“…To assess the safety of Pfizer-BioNTech COVID-19 mRNA BNT162b2 vaccine (Comirnaty®) among patients with the anamnesis of paediatric inflammatory syndrome temporally associated with COVID-19 (PIMS-TS), we conducted a prospective cohort study of 21 patients with history of PIMS (PIMS group, median age 7.4 years, 71% male) and 71 healthy controls without such an anamnesis (CONTROL group, median age 9.0 years, 39% male) aged 5–18 years. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4220por Meegdes, Marissa, Geurts, Sandra M.E., Erdkamp, Frans L.G., Dercksen, M. Wouter, Vriens, Birgit E.P.J., Aaldering, Kirsten N.A., Pepels, Manon J.A.E., van de Winkel, Linda M.H., Peters, Natascha A.J.B., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., de Fallois, Aude J.O., van Kats, Maartje A.C.E., Tjan-Heijnen, Vivianne C.G.“…FUNDING: The SONABRE Registry is supported by the Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); 10.13039/100004336Novartis BV; 10.13039/100004337Roche; 10.13039/100004319Pfizer; and 10.13039/100004312Eli Lilly & Co. Funding sources had no role in the writing of the manuscript.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto